An update on drug combinations for treatment of myeloma

Author： Srikanth Muralikrishnan Davies Faith E Morgan Gareth J

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.17, Iss.1, 2008-01, pp. : 1-12

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Drug Combinations for Dyslipidemia and Obesity Treatment in Metabolic Syndrome

Current Pharmaceutical Design, Vol. 15, Iss. 29, 2009-10 ,pp. : 3446-3462

Bentham Science Publishers

Access to resources Recommend Favorite

Thalidomide as an Antiangiogenic Drug in the Treatment of Multiple Myeloma

Letters in Drug Design & Discovery, Vol. 1, Iss. 2, 2004-04 ,pp. : 135-136

Bentham Science Publishers

Access to resources Recommend Favorite

Management of Focal-Onset Seizures: An Update on Drug Treatment

By Johannessen Svein I.

Drugs, Vol. 66, Iss. 13, 2006-01 ,pp. : 1701-1725

Adis International

Access to resources Recommend Favorite

Fixed Drug Combinations for the Acute Treatment of Migraine: Place in Therapy

By Loder Elizabeth

CNS Drugs, Vol. 19, Iss. 9, 2005-01 ,pp. : 769-784

Adis International

Access to resources Recommend Favorite

Update on COX-2 inhibitor patents with a focus on optimised formulation and therapeutic scope of drug combinations making use of COX-2 inhibitors

By Puhlmann Ulrike Schäfer Dirk Ziemann Christina

Expert Opinion on Therapeutic Patents, Vol. 16, Iss. 4, 2006-04 ,pp. : 403-430

Informa Healthcare

Access to resources Recommend Favorite